0001140361-13-001149.txt : 20130104 0001140361-13-001149.hdr.sgml : 20130104 20130104171516 ACCESSION NUMBER: 0001140361-13-001149 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130104 DATE AS OF CHANGE: 20130104 EFFECTIVENESS DATE: 20130104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Altheus Therapeutics Inc CENTRAL INDEX KEY: 0001414163 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-174656 FILM NUMBER: 13512904 BUSINESS ADDRESS: STREET 1: 755 Research Parkway STREET 2: Suite 435 CITY: Oklahoma City STATE: OK ZIP: 73104 BUSINESS PHONE: (405) 319-8177 MAIL ADDRESS: STREET 1: 755 Research Parkway STREET 2: Suite 435 CITY: Oklahoma City STATE: OK ZIP: 73104 D/A 1 primary_doc.xml X0706 D/A LIVE 0001414163 Altheus Therapeutics Inc 755 RESEARCH PARKWAY SUITE 435 OKLAHOMA CITY OK OKLAHOMA 73104 (405) 319-8177 DELAWARE None None Corporation true Dennis Schafer 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Director Richard F. Harty, MD 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Promoter Brian L. Clevinger c/o Prolog Ventures, LLC 7733 Forsyth Blvd., Suite 1440 St. Louis MO MISSOURI 63105 Director William Paiva ONEOK Plaza 100 W. 5th St., Suite 705 Tulsa OK OKLAHOMA 74103 Director Thomas L. Shoaf Stifel Nicolaus Company, Inc. One Financial Plaza, 501 N. Broadway St. Louis MO MISSOURI 63102 Director Douglas A. Branch 101 N. Robinson Corporate Tower, 13th Floor Oklahoma City OK OKLAHOMA 73102 Director Dayton T. Reardan 755 Research Parkway Suite 435 Oklahoma City OK OKLAHOMA 73104 Executive Officer Biotechnology No Revenues 06 true 0001140361-12-014470 2012-02-24 false true false 967 5850851 5850851 0 The Total Offering Amount was initially $7,734,919, but the Total Amount Sold after all closings was $5,850,851, which includes $3,000,000 in cash and $2,325,851 upon conversion of notes at the initial closing, and $525,000 in cash at the final closing. false 20 0 0 200000 true Includes legal fees paid to a law firm affiliated with a director of the Company and deferred payments owed to certain of the Company's executive officers and directors. false Altheus Therapeutics Inc Douglas A. Branch Douglas A. Branch Secretary 2013-01-04